MedTrace Logo

Effect of the XP1100RF Therapy on Thighs Circumference Reduction

NCT02527369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2020-07-13

No results posted yet for this study

Summary

This study was designed to demonstrate safety and efficacy of the XP1100RF for non-invasive temporary reduction of thighs circumference by disruption of adipocyte cells.

Conditions

  • Thighs Circumferential Reduction
  • Subcutaneous Fat Cell Disruption

Interventions

DEVICE

XP1100RF

Treatment of adipose tissue within the fat layer with XP1100RF device.

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Principal Investigators

  • Radina Denkova, MD · Aesthe Beauty Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02527369 on ClinicalTrials.gov